{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T16:02:08Z","timestamp":1781020928030,"version":"3.54.1"},"reference-count":12,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["CHEST"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.chest.2026.02.002","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T09:12:57Z","timestamp":1780996377000},"page":"1432-1433","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Is It Time to Focus Efforts to Better Understand Group 3 Pulmonary Hypertension in Patients With Cystic Fibrosis and Non-Cystic Fibrosis Bronchiectasis?"],"prefix":"10.1016","volume":"169","author":[{"given":"Zoe M.","family":"Lyon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4586-959X","authenticated-orcid":false,"given":"Nicholas A.","family":"Kolaitis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.chest.2026.02.002_bib1","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01200-2024","article-title":"Pulmonary hypertension associated with lung diseases","volume":"64","author":"Shlobin","year":"2024","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.chest.2026.02.002_bib2","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01324-2024","article-title":"Definition, classification and diagnosis of pulmonary hypertension","volume":"64","author":"Kovacs","year":"2024","journal-title":"Eur Respir J"},{"issue":"8","key":"10.1016\/j.chest.2026.02.002_bib3","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.healun.2010.04.006","article-title":"Prevalence of pulmonary hypertension in end-stage cystic fibrosis and correlation with survival","volume":"29","author":"Tonelli","year":"2010","journal-title":"J Heart Lung Transplant"},{"issue":"8","key":"10.1016\/j.chest.2026.02.002_bib4","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1164\/rccm.201407-1382OC","article-title":"Pulmonary hypertension in cystic fibrosis with advanced lung disease","volume":"190","author":"Hayes","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.chest.2026.02.002_bib5","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/j.chest.2025.12.047","article-title":"Pulmonary hypertension prevalence and significance in lung transplant recipients with cystic fibrosis and non-cystic fibrosis bronchiectasis","volume":"169","author":"Chandel","year":"2026","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.chest.2026.02.002_bib6","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.21037\/jtd-23-1316","article-title":"Prevalence of pulmonary artery dilation in non-cystic fibrosis bronchiectasis: a computed tomography analysis from a cohort of the US Bronchiectasis and Nontuberculous Mycobacteria Research Registry","volume":"16","author":"Karamooz","year":"2024","journal-title":"J Thorac Dis"},{"issue":"2","key":"10.1016\/j.chest.2026.02.002_bib7","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1378\/chest.07-1639","article-title":"Right and left ventricular function and pulmonary artery pressure in patients with bronchiectasis","volume":"133","author":"Alzeer","year":"2008","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.chest.2026.02.002_bib8","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1097\/HJH.0000000000003782","article-title":"Pulmonary vascular resistance predicts the mortality in patients with bronchiectasis-associated pulmonary hypertension","volume":"42","author":"Xu","year":"2024","journal-title":"J Hypertens"},{"issue":"6","key":"10.1016\/j.chest.2026.02.002_bib9","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.2214\/AJR.10.5221","article-title":"Pulmonary hypertension in patients with bronchiectasis: prognostic significance of CT signs","volume":"196","author":"Devaraj","year":"2011","journal-title":"AJR Am J Roentgenol"},{"issue":"4","key":"10.1016\/j.chest.2026.02.002_bib10","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1056\/NEJMoa2008470","article-title":"Inhaled treprostinil in pulmonary hypertension due to interstitial lung disease","volume":"384","author":"Waxman","year":"2021","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.chest.2026.02.002_bib11","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00172-2024","article-title":"Inhaled treprostinil in pulmonary hypertension associated with COPD: PERFECT study results","volume":"63","author":"Nathan","year":"2024","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.chest.2026.02.002_bib12","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1164\/rccm.201210-1865OC","article-title":"Clinical risk factors for primary graft dysfunction after lung transplantation","volume":"187","author":"Diamond","year":"2013","journal-title":"Am J Respir Crit Care Med"}],"container-title":["CHEST"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369226001510?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369226001510?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T15:25:50Z","timestamp":1781018750000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369226001510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":12,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0012369226001510"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2026.02.002","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is It Time to Focus Efforts to Better Understand Group 3 Pulmonary Hypertension in Patients With Cystic Fibrosis and Non-Cystic Fibrosis Bronchiectasis?","name":"articletitle","label":"Article Title"},{"value":"CHEST","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2026.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2025.12.047","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American College of Chest Physicians. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}